Olympus and Proximie Forge Partnership to Transform Digital Healthcare

By Melike Belenli Gümüş

October 29, 2024

The press release from Olympus Europa highlights a significant partnership between Olympus Corporation and Proximie, a global health technology company. This collaboration is centred around Proximie’s innovative health tech platform, which aims to digitise operating rooms and enhance patient care. The newly formed partnership is designed to improve patient outcomes and clinical practices by fostering collaboration and knowledge sharing among healthcare professionals.

Partnership Overview

Olympus Corporation has entered a global partnership with Proximie to offer a market-leading health tech platform that focuses on digitising operating rooms. This partnership is essential for improving patient care and enhancing clinical practices through better collaboration among medical staff.

Proximie’s Platform

Proximie’s cloud-based solution enables physicians to share real-time live clinical video, audio, and imagery from the operating room (OR) with colleagues and vendor partners globally. This facilitates telecollaboration, secure training sessions, and the capture of video content from any source.

Key Features of Proximie’s Platform

The platform is designed to be device-agnostic, enabling compatibility with various devices and allowing access from any browser or mobile device. It supports up to four high-definition, low-latency video feeds, providing essential views of procedures. To facilitate real-time collaboration, the platform includes features such as annotation, chat, and screen sharing. Moreover, the platform streamlines installation by offering tablet control and the ability to connect multiple video signals, making it easy to set up in any tower or clinical space. For moderation and privacy, the platform incorporates comprehensive controls and privacy features to manage sessions effectively. Furthermore, the system offers content management capabilities, allowing users to transform individual expertise into shareable video content.

Regional Agreement

In the EMEA region, Olympus and Proximie have entered into a Reseller Partner Agreement. This partnership allows Olympus to distribute Proximie’s health tech platform products. Customers across Europe, the Middle East, and Africa will now have access to these innovative solutions.

Objectives and Benefits

The partnership aims to break down learning barriers, providing healthcare professionals with the knowledge needed to enhance patient care. The initiative aims to promote clinical and operational best practices by increasing teaching opportunities. It seeks to reach a broader audience of learners. The collaboration plays a crucial role in the future of digital healthcare. Surgeons can meet the rising demand for diagnostic and interventional care, thereby improving global healthcare equity.

Statements from Executives

Engin Demirel, Global Head of Commercialization for Endoscopy Solutions Ecosystem (ESE) at Olympus Corporation, expressed excitement about the partnership, highlighting its potential to improve patient outcomes. Dr. Nadine Hachach-Haram, the Proximie founder and CEO, emphasised the shared commitment to widening access to surgical and procedural knowledge through the health tech platform, ultimately improving global healthcare equity.

About Olympus and Proximie

Olympus: A global medical technology company committed to making people’s lives healthier, safer, and more fulfilling. Olympus partners with healthcare professionals to deliver best-in-class solutions for early detection, diagnosis, and minimally invasive treatment.

Proximie: A global health technology platform focused on digitising operating and diagnostic rooms. The goal of Proximie’s health tech platform is to make surgery more accessible, efficient, and effective through cutting-edge, cloud-based technology.

Reference url

Recent Posts

Simponi Pediatric Approval: FDA Grants First Pediatric Indication for Ulcerative Colitis Treatment

By HEOR Staff Writer

October 9, 2025

The U.S. Food and Drug Administration has granted Simponi pediatric approval for Johnson & Johnson's Simponi (golimumab), which is intended for children with moderately to severely active ulcerative colitis who weigh at least 15 kg. This historic approval is backed by data from the PURSUIT pr...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strategy for the NHS
The National Institute for Health and Care Excellence (NICE) is expanding its technology appraisals programme, and starting April 2026, this will include digital health technologies that are placed on an equal legal footing with medicines in the NHS. This initiative forms part of the NHS 10-year ...
Health Misinformation Autism: The Dangers of Politicized Science in Vaccine and Drug Discourse

By João L. Carapinha

October 7, 2025

The BMJ article “Tylenol, vaccines, and autism: the medical mayhem of the MAGA methodologists” argues that political and ideological actors, notably aligned with the MAGA movement, are promoting health misinformation about autism, vaccines, and paracetamol. They amplify preliminary, misinterprete...